Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Investigate the PRevention of OM-85 on Bronchiectasis Exacerbation (iPROBE): a Multicenter, Randomised, Double-dummy, Placebo-controlled Clinical Trial in Chinese Patients

NCT01968421 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT01968421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01968421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Investigate the PRevention of OM-85 on Bronchiectasis Exacerbation (iPROBE): a Multicenter, Randomised, Double-dummy, Placebo-controlled Clinical Trial in Chinese Patients
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2015
Completion date
November 23, 2018
Enrollment
196 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis with acute exacerbation